We didn't miss any boats on this - all they have done is to demonstrate their technology in the lab, and they've published a peer-reviewed article, as we did several years ago. They have no regulatory approval, no patents, which as we know can be extremely challenging.
We are a few steps ahead, and hopefully nearing the end of the beginning.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.